NYSE

ELI LILLY AND CO (LLY)

Currency USD

Company Overview

Eli Lilly and Company, one of the world's largest pharmaceutical companies, boasts a diversified product profile including a solid lineup of new successful drugs. It also has a dependable pipeline as it navigates through challenges like patent expirations of several drugs and rising pricing pressure on its U.S. diabetes franchise. Its pharmaceutical product categories are neuroscience, diabetes, oncology, immunology and others. Over the past few years, Lilly has been actively seeking acquisitions and in-licensing deals to boost its product portfolio and pipeline. The purchase of ImClone Systems brought with it cancer compound, Erbitux. The acquisition of ICOS Corporation gave Lilly full control over erectile dysfunction drug, Cialis. Its other acquisitions include Hypnion, Inc., CoLucid Pharmaceuticals added Reyvow for acute migraine, Loxo Oncology and Dermira. Lilly has collaboration agreements with several companies including Incyte, Boehringer Ingelheim and Innovent Biologics among others.

Contact Details

Address
LILLY CORPORATE CTR
City
INDIANAPOLIS
State
IN
Country
USA
Zip Code
46285
Phone Number
317-276-2000
Website
-

Financial Highlights

Day Range

The price range a stock has traded at during the most recent trading period.

-
-
5 Day Range

The price range a stock has traded at during the previous 5 days.

-
-
3 Month Range

The price range a stock has traded at during the previous 3 months.

-
-
52 Week Range

The price range a stock has traded at during the previous 52 weeks.

-
-
Previous Close

The closing price of a stock from the previous day.

-
Open

The price of the stock at the start of today’s market opening.

-
Bid

The amount of money a trader is willing to pay per share for a given stock. 

x
-
Ask

The amount of money a seller wants per share of a given stock.

x
-
Volume

The number of shares traded in a given period. This number illustrates the active interest in the stock at any time.

-
Avg. Volume

The average number of shares traded in a given day.

-
Dividend Yield

A company's annual dividend expressed as a percentage of its current stock price.

-
Recent Dividend

The value a shareholder receives from a company they are invested in for holding their shares.

-
Beta

A measurement of the stock’s volatility in comparison to the market as a whole.

-

Shareholding

Shares Outstanding

Number of shares currently held by investors, including restricted shares owned by the company's officers and insiders.

-
Insider Shareholders

The percentage of shares owned by any officer or board director of the company, including their related or affiliated individuals, families, entities and trusts.

-
Institutional Shareholders

The percentage of shares owned by an institution such as a mutual fund, bank or insurance company.

-
Market Cap

The market value of a company’s outstanding shares. It is used as a measurement tool to determine how large a company is.

-
Revenue TTM

The amount of money a company has made for the trailing twelve-month period.

-
Net Income TTM

A measurement of how much profit they are retaining for the trailing twelve-month period.

-
P/E Ratio

The Price to Earnings (P/E) ratio, is calculated by dividing the stock's most recent share price by the sum of the diluted earnings per share.

-
EPS TTM

Earnings Per Share (EPS) TTM is a company's profit for the trailing twelve-month period divided by its number of common outstanding shares.

-
1 Year Return

A measurement of how much the stock has increased or decreased in the last year.

-

There is no stock data currently available for this time period, please select another option.

Please wait, gathering market data...

Latest News

View More
News |

Mower, co-inventor of implantable defibrillator, dies at 89

View More
News |

EXPLAINER: COVID-19 pills must be taken within 5 days

View More
News |

US pulls GSK's COVID drug as omicron sibling dominates cases

View More
News |

Pressure mounts for multinationals in Russia to leave

View More
News |

Not all Western companies sever ties to Russia over Ukraine

View More
News |

US authorizes new antibody drug to fight omicron

View More